Risk factors for recurrent retinal detachment;Les facteurs de récidive du décollement de rétine

Journal Francais d'Ophtalmologie

Volumn 30, Issue 8, 2007, Pages 847-851

  Conrath, J ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Proliferative vitreoretinopathy; Recurrence; Retinal detachment

Indexed keywords

EID: 35649019667     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(07)92625-X     Document Type: Conference Paper

References (44)

1. Bonnet M. Les facteurs cliniques de risque de la PVR dans le décollement rhegmatogène de la rétine. J Fr Ophthalmol, 1994;17:530-40.
2. Ryan SJ. Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. Am J Ophthalmol, 1993;15:1-20.
3. Gonin J. The treatment of detached retina by searing the retinal tears. Arch Ophthalmol, 1930;4:621-5.
4. Dunnington JH, Macine JP. Detachment of the retina. Arch Ophthalmol, 1935;13:191-200.
5. Hughes WF. Evaluation of results of retinal detachment surgery. Trans Am Acad Ophthalmol Otolaryngol, 1952;56:439-48.
6. Tolentino FI, Schepens CL, Freeman HM. Massive Preretinal Retraction. Arch Ophthalmol, 1967;78:16-22.
7. Chignell AH, Fison LG, Davies EWG, Hartley RE, Gundry MF. Failure in retinal detachment surgery. Br J Ophthalmol, 1973;57:525-30.
8. Lincoff H, Kreissig J, Goldbaum M. Reasons for failure in non-drainage operations. In: Streiff EB (ed), Modern Problems in Ophthalmology. Basel: S Karger; 1974. p. 40-8.
9. Rachal WF, Burton TC. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol, 1979;97:480-3.
10. Stangos AN, Petropoulos IK, Brozou CG, Kapetanios AD, Whatham A, Pournaras CJ. Pars-plana vitrectomy alone vs vitrectomy with scleral buckling for primary rhegmatogenous pseudophakic retinal detachment. Am J Ophthalmol, 2004;138:952-8.
11. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol, 1995;79:953-60.
12. Foster RB, Meyers SM. Recurrent retinal detachment more than 1 year after reattachment. Ophthalmology, 2002;109:1821-7.
13. th ed. San Francisco: American Academy of Ophthalmology; 1989. p. 155-9.
14. nd ed. Philadelphia: JB Lippincott, 1988.
15. Mietz H, Heimann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases. Br J Ophthalmol, 1995;79:874-7.
16. Pastor CJ. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998;43:3-18.
17. Widemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol, 1992;36:373-84.
18. Morino I, Hiscott PS, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol, 1990;74:393-9.
19. Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol, 1997;115:237-41.
20. Wilkins RB, Kulwin DR. Wound healing. Ophthalmology, 1979;86:507-10.
21. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 1983;90:121-5.
22. Lean JS, Stern WH, Irivine A, Azen SP. The Silicone Study Group. Classification of proliferative vitreoretinopathy used in the Silicone Study. Ophthalmology, 1989;96:756-71.
23. Machemer R, Aaberg TM, Freeman HM, Irvine A, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol, 1991;112:159-65.
24. Amadieh H, Entezari M, Soheilian M, Asarmina M, Dehghan MH, Mashayekhi A, et al. Factors influencing anatomic and visual results in primary scleral buckling. Eur J Ophthalmol, 2000;10:153-9.
25. Yoshino Y, Ideta H, Nagasaki H, Uemura A. Comparative study of clinical factors predisposing patients to proliferative vitreoretinopathy. Retina, 1989;9:97-100.
26. Girard P, Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina, 1994;14:417-24.
27. Bonnet M. The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor. Graefe's Arch Clin Exp Ophthalmol, 1988;226:201-5.
28. Malbran E, Dodds RA, Hulsbus R, Charles DE, Buonsanti JL, Adrogue E. Retinal break type and proliferative vitreoretinopathy in nontraumatic retinal detachment. Graefe's Arch Clin Exp Ophthalmol, 1990;228:423-5.
29. Bonnet M, Guenoun S. Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR. Graefe's Arch Clin Exp Ophthalmol, 1995;233:789-91.
30. Singh AK, Michels RG, Glaser BM. Scleral indentation following cryotherapy and repeat cryotherapy enhance release of viable pigment epithelial cells. Retina, 1986;6:77-80.
31. Kon CH, Asaria RHY, Occleston NL, Khaw PT, Aylward GW. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol, 2000;84:506-11.
32. Dieudonné SC, La Heij EC, Diedreren R, Kessels AGH, Liem ATA, Kijlstra A, et al. High TGF-β2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci, 2004;45:4113-8.
33. Asaria RHY, Kon CH, Bunce C, Charteris DG, Wong D, Luther PJ, et al. How to predict proliferative vitreoretinopathy. A prospective study. Ophthalmology, 2001;108:1184-1186.
34. Asaria RHY, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy. Results from a randomized, double-blind, controlled clinical trial. Ophthalmology, 2001;108:1179-83.
35. Widemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol, 1988;126:550-9.
36. Foster RE, Meyers SM. Recurrent retinal detachment more than 1 year after reattachment. Ophthalmology, 2002;109:1821-7.
37. Girard P, Mayer F, Karpouzas I. Late recurrences of retinal detachement. Ophthalmologica, 1997;211:247-50.
38. Girard P, Farchoukh B, Karpousas J, Gaudric A. Récidives tardives de décollement de rétine. J Fr Ophthalmol, 2005;28:1S40.
39. Le Rouic JF, Behar-Cohen F, Azan F, Bertin S, Bettembourg O, Rumen F, et al. Vitrectomie sans indentation versus chirurgie ab-externo dans le décollement de rétine du pseudophake : étude comparative rétrospective. J Fr Ophtalmol, 2002;25:240-5.
40. Amadieh H, Moradian S, Faghini H, Parvaresh MM, Ghanbari H, Mehryar M, et al. Anatomic and visual outcome of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment : six-month follow-up results of a single operation-report no. 1. Ophthalmology, 2005;112:1421-9.
41. McLeod D. Is it time to call time on the scleral buckle? Br J Ophthalmol, 2004;88:1357-9.
42. Tognetto D, Minutola D, Sanguinetti G, Ravalico G. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment. Ophthalmology, 2005;112:1574.e1-1574. e8.
43. Laidlaw AH, Karia N, Bunce C, Aylward GW, Gregor ZJ. Is prophylactic 360° laser retinopexy protective? Risk factors for retinal redetachment after removal of silicone oil. Ophthalmology, 2002; 109:153-8.
44. Jonas JB, Knorr HL, Rank RM, Budde WM. Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol, 2001;85:1203-7.